Clinical Trial of Ruxian Zengsheng No. 1 Decoction

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A prospective, open, randomized, controlled phase II clinical study is planned to clarify the efficacy and related adverse reactions of Mammary Glandular Hyperplasia No. 1 Decoction in the treatment of liver-qi stagnation type breast hyperplasia, relieve the pain of patients with breast hyperplasia, and improve the quality of life of patients.
Epistemonikos ID: a0b428b13390765052e88c2a0379162a9d997655
First added on: May 08, 2024